Dermatologicals saw a modestly positive performance in 2019, notably due to wider distribution, higher levels of self-medication and the growing use of natural options. However, retail current value sales of dermatologicals are expected to decline over 2020 as a whole, with few exceptions (vaginal antifungals, nappy (diaper) rash treatments and topical germicidals/antiseptics).
One of the first consequences of COVID-19 in Belgium was the spike in demand for hydroalcoholic gels (not included in the research for this market). Due to shortages of hydroalcoholic gels in the first weeks of the lockdown, many consumers used topical germicidals/antiseptics as alternatives.
Local and regional manufacturers are a major presence in dermatologicals in Belgium. Benelux manufacturers like Janssen-Cilag, Omega Pharma Belgium, Will Pharma and Tilman are often popular players in a fragmented competitive landscape.
Dermatologicals is expected to recover to register retail value sales growth, albeit marginal, at constant 2020 prices in the short term. Dermatologicals considered less crucial than acetaminophen or vitamins are set benefit from their return to retail shelves and the reopening of Medi-Market with the end of the lockdown.
The performance of dermatologicals is likely vary according to type in the forecast period. Topical germicidals/antiseptics, which enjoyed a surge in demand during the COVID-19 lockdown, is likely to see a return to sales decline, especially as the shortage of hydroalcoholic gels has ended.
As in other areas of consumer health, consumers are turning to more natural and herbal alternatives in search of milder and safer, but still effective, dermatologicals. Over the forecast period, dermatologicals is expected to benefit from the contribution of more natural alternatives, as illustrated by the successful “liniment” trend in the country.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page